News

Explore by Category
News

KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)

April 20, 2021

Data from 1,325 CANVAS Participants with Baseline DKD Scored with KidneyIntelX Presented at International Society of Nephrology World Congress of Nephrology 2021 NEW YORK, April 20, 2021 – Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX)…

 
 
News

Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions

April 08, 2021
 
News

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

April 05, 2021
 
News

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

February 24, 2021
 
News

American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health

February 04, 2021
 
News

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

January 14, 2021
 
News

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

January 05, 2021
 
News

RenalytixAI Receives California Commercial Laboratory Certification

September 22, 2020
 
News

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

September 18, 2020
 
News

RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX

August 26, 2020